How severe is CVE-2020-16222?

CVE-2020-16222 has a CVSS 3.x base score of 8.8, rated high severity. It is exploitable over an adjacent network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.

Is CVE-2020-16222 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (42nd percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2020-16222?

CVE-2020-16222 primarily affects Philips Patient Information Center Ix. In total, 4 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.

How do I fix CVE-2020-16222?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.

When was CVE-2020-16222 published?

CVE-2020-16222 was published on 2020-09-11 and last updated on 2026-06-17.

CVE-2020-16222

CVE-2020-16222 is a high-severity vulnerability in Philips Patient Information Center Ix with a CVSS 3.x base score of 8.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-287.

Key facts

Severity: High (CVSS 3.x base score 8.8)
CVSS v2: 5.8
EPSS exploit prediction: 1% (42nd percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-287
Affected product: Philips Patient Information Center Ix
Published: 2020-09-11
Last modified: 2026-06-17

Description

In Patient Information Center iX (PICiX) Version B.02, C.02, C.03, and PerformanceBridge Focal Point Version A.01, when an actor claims to have a given identity, the software does not prove or insufficiently proves the claim is correct.

Frequently asked questions

What is CVE-2020-16222?: In Patient Information Center iX (PICiX) Version B.02, C.02, C.03, and PerformanceBridge Focal Point Version A.01, when an actor claims to have a given identity, the software does not prove or insufficiently proves the claim is correct.
How severe is CVE-2020-16222?: CVE-2020-16222 has a CVSS 3.x base score of 8.8, rated high severity. It is exploitable over an adjacent network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2020-16222 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (42nd percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2020-16222?: CVE-2020-16222 primarily affects Philips Patient Information Center Ix. In total, 4 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2020-16222?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2020-16222 published?: CVE-2020-16222 was published on 2020-09-11 and last updated on 2026-06-17.

References

Affected products (4)

cpe:2.3:a:philips:patient_information_center_ix:b.02:*:*:*:*:*:*:*
cpe:2.3:a:philips:patient_information_center_ix:c.02:*:*:*:*:*:*:*
cpe:2.3:a:philips:patient_information_center_ix:c.03:*:*:*:*:*:*:*
cpe:2.3:a:philips:performancebridge_focal_point:a.01:*:*:*:*:*:*:*

More vulnerabilities in Philips Patient Information Center Ix

CVE-2020-16212 — Medium (CVSS 6.8): In Patient Information Center iX (PICiX) Versions B.02, C.02, C.03, the product exposes a resource to the wrong control…
CVE-2021-43548 — Medium (CVSS 6.5): Patient Information Center iX (PIC iX) Versions C.02 and C.03 receives input or data, but does not validate or…
CVE-2020-16224 — Medium (CVSS 6.5): In Patient Information Center iX (PICiX) Versions C.02, C.03, the software parses a formatted message or structure but…
CVE-2020-16216 — Medium (CVSS 6.5): In IntelliVue patient monitors MX100, MX400-550, MX600, MX700, MX750, MX800, MX850, MP2-MP90, and IntelliVue X2 and X3…
CVE-2020-16228 — Medium (CVSS 6.4): In Patient Information Center iX (PICiX) Versions C.02 and C.03, PerformanceBridge Focal Point Version A.01,…
CVE-2021-43552 — Medium (CVSS 6.1): The use of a hard-coded cryptographic key significantly increases the possibility encrypted data may be recovered from…

All CVEs affecting Philips Patient Information Center Ix →

Other CWE-287 (Improper Authentication) vulnerabilities

CVE-2026-45480 — Critical (CVSS 10.0): Improper authentication in Azure Active Directory allows an unauthorized attacker to elevate privileges over a network.
CVE-2026-46389 — Critical (CVSS 10.0): UDS Identity Config builds the Keycloak configuration image (realm, plugins, theme, truststore, JARs) consumed by UDS…
CVE-2026-10611 — Critical (CVSS 10.0): An authentication bypass vulnerability exists in MISP when LDAP mixed authentication is enabled with OTP enforcement.…
CVE-2026-47280 — Critical (CVSS 10.0): Improper authentication in Azure Resource Manager (ARM) allows an unauthorized attacker to elevate privileges over a…
CVE-2026-42822 — Critical (CVSS 10.0): Improper authentication in Azure Local Disconnected Operations allows an unauthorized attacker to elevate privileges…
CVE-2026-20182 — Critical (CVSS 10.0): May 2026: This security advisory provides the details and fix information for a vulnerability that was discovered and…

Browse all CWE-287 (Improper Authentication) vulnerabilities →